Commentary on the Developing UK Government Position on Healthy Longevity

One option for patient advocacy for the treatment of aging as a medical condition is to petition governments and large international organizations such as the World Health Organization to adjust their positions on research funding and goals in medicine. This a fairly popular path, for all that I think it not terribly effective at speeding up the cutting edge of research and development. Large organizations of any sort are inherently conservative, and tend to get meaningfully involved in new fields of human endeavor only long after their support would have been truly influential. Nonetheless, numerous examples of government focused initiatives have emerged from our community over the past decade. They include the Longevity Dividend initiative, petitioning the US government for greater public funding for translational aging research

From http://besthealthnews.com/2019/07/commentary-on-the-developing-uk-government-position-on-healthy-longevity/?utm_source=rss&utm_medium=rss&utm_campaign=commentary-on-the-developing-uk-government-position-on-healthy-longevity

from
https://healthnews010.wordpress.com/2019/07/27/commentary-on-the-developing-uk-government-position-on-healthy-longevity/

From https://jamesjohnson10.blogspot.com/2019/07/commentary-on-developing-uk-government.html

from
https://jamesjohnson10.wordpress.com/2019/07/27/commentary-on-the-developing-uk-government-position-on-healthy-longevity/